The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Prevalence and Predictors of Corticosteroid-Related Hyperglycemia in Hospitalized Patients
Abstract
Objective To investigate the prevalence of and risk factors for hyperglycemia in hospitalized patients receiving corticosteroids, which have been identified as an independent predictor of hyperglycemia.Methods We conducted a retrospective review of electronic medical records of patients admitted to the general medicine service at a university hospital during a 1-month period. Pharmacy charges were used to identify patients receiving high doses (> or = 40 mg/day of prednisone or the equivalent) of corticosteroids for at least 2 days. Occurrence of hyperglycemia and the presence of risk factors, including history of diabetes, duration of corticosteroid therapy, concurrent parenteral nutrition, antibiotic therapy, use of medications associated with hyperglycemia, severity of illness scores, and hospital length of stay, were determined. Patients experiencing multiple episodes of hyperglycemia (glucose levels > or = 200 mg/dL) were compared with those who had < or = 1 hyperglycemic episode. Patients without a history of diabetes were assessed separately.Results During the 1-month study period, 66 of 617 patients received high doses of corticosteroids, but only 50 of the 66 had glucose measurements. Hyperglycemia was documented in 32 of these 50 patients (64%), and multiple hyperglycemic episodes occurred in 26 (52%). A history of diabetes was documented in 12 of 26 patients who experienced multiple episodes, in comparison with 4 of 24 patients with < or = 1 episode of hyperglycemia (P = 0.035). Among patients without a history of diabetes, 19 of 34 (56%) had hyperglycemia at least once. Patients with multiple episodes of hyperglycemia had more comorbid diseases, longer duration of corticosteroid therapy, and longer duration of hospital stay.Conclusion Hyperglycemia occurs in a majority of hospitalized patients receiving high doses of corticosteroids. In light of the poor outcomes associated with hyperglycemia, protocols targeting its detection and management should be available for patients who receive corticosteroid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk of DM was greater in subjects with abdominal adiposity or a genetic predisposition to DM and in those taking higher doses of GCs and for longer periods (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [198]
In the citing paper
“their usage is associated with a significant number of metabolic adverse effects, including insulin resistance, visceral adiposity, dyslipidaemia and fasting and postprandial hyperglycaemia.2”
From Twenty‐four‐hour profiles of plasma glucose, insulin, C‐peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short‐term, medium‐dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action (2012) · cites this paper as [2]
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Malmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Glucocorticoids and the risk for initiation of hypoglycemic therapy
Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314
Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly
Blackburn, D. F., Hux, J. E., & Mamdani, M. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10649.x · Cited by 186
Yount, R. J., & Vries, J. K. (1991) · Information Processing & Management · doi:10.1016/0306-4573(91)90091-y · Cited by 100
Steroid‐Induced Diabetes Mellitus and Related Risk Factors in Patients with Neurologic Diseases
Iwamoto, T., Kagawa, Y., Naito, Y., Kuzuhara, S., & Kojima, M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.5.508.33355 · Cited by 79
DRUG SELECTION AND THE MANAGEMENT OF CORTICOSTEROID-RELATED DIABETES MELLITUS
Hoogwerf, B. J., & Danese, R. D. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70083-1 · Cited by 77
Flagged first, then by citations
Research works printed but not linked: 1
- Inzucchi, 2003, Risk factors for poor glycemic control in a medical intensive care unit (ICU) [abstract], Diabetes., 52, A96
Cited by
Sorted by citations
Items 201–244 of 244
Hipomanía y corticoides en pacientes oncológicos. Reporte de un caso y revisión de la literatura
Paulina Troncoso, G., & Mosher, P. J. (2018) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272018000300169 · Cited by 1
Madhavan, A., Murali, K., Raghavendra, V., & Joshi, A. K. R. (2020) · EXCLI journal · doi:10.17179/excli2020-2814 · Cited by 1
Other Specific Types of Diabetes
Forlenza, G. P., Moran, A., & Nathan, B. M. (2018) · Europe PMC (PubMed Central) · Cited by 1
Inpatient Management of Type 2 Diabetes Mellitus
Lee, H. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_41 · Cited by 1
Necrotizing fasciitis – a complication of autoimmune skin blistering diseases?
Jurišić, M., Nikolić, G., Živanović, M. N., & Stojičić, M. (2023) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17694 · Cited by 1
In‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Re: hyperglycemia after kidney transplantation: frequency and risk factors.
Ganji, M. R. (2013) · Iranian Journal of Kidney Diseases
Norton, S. (2012) · University of Hertfordshire Research Archive (University of Hertfordshire)
L’insulinothérapie à l’hôpital
Feldman-Billard, S., & Altman, J. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.02.319
Corticothérapie dans le cancer de la prostate résistant à la castration
Lebdai, S., Branchereau, J., Robert, G., TAILLE, A. D. L., & Bouchaert, P. (2013) · The French Journal of Urology · doi:10.1016/s1166-7087(13)70043-5
[Guidelines for the management of hyperglycaemia in hospitalised adult patients].
Gornik, I., Rahelić, D., Husedzinović, N., Gasparović, V., Ivanovic, D., Krznarić, Ž., & Pavlić-Renar, I. (2014) · PubMed
Corticothérapie dans le cancer de la prostate résistant à la castration
Angers, C., & Nantes, C. (2013)
In‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., & James, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch34
Цукровий діабет, індукований екзогенним введенням глюкокортикостероїдів
Nykytiuk, L. A. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.8.80.2016.89532
SMJERNICE ZA ZBRINJAVANJE HIPERGLIKEMIJE U ODRASLIH HOSPITALIZIRANIH BOLESNIKA
Gornik, I., Rahelić, D., Husedžinović, I., Gašparović, V., Ivanovic, D., Krznarić, Ž., & Pavlić-Renar, I. (2014) · University of Zagreb University Computing Centre (SRCE)
Jafar, N. S., Edriss, H., Islam, E. A., & NUGENT, K. M. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Gestione del diabete nel paziente oncologico
Gallo, M., & Belcastro, S. (2018) · L Endocrinologo · doi:10.1007/s40619-018-0455-y
Principles of Care in the Diabetic Surgical Patient
Khazai, N. B., & Hamdy, O. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_6
Type 2 Diabetes Mellitus in Patients with a Prior History of Corticosteroid-induced Hyperglycemia
DeZubay, J., Drew, R. H., Smith, J., Mills, E., Bell, T. L., & Holland, M. (2019) · Journal of Contemporary Pharmacy Practice · doi:10.37901/jcphp17-00023
Nurcahyo, W. I., & Sayoga, H. J. (2019) · JAI (Jurnal Anestesiologi Indonesia) · doi:10.14710/jai.v11i1.23942
Metabolische und endokrine Toxizität antineoplastischer Substanzen
WICKI, A. N. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_284-1
Xie, W., Liu, N., Wang, X., Xie, W., Li, D., & Sheng, X. (2020) · Research Square · doi:10.21203/rs.3.rs-132433/v1
Glycemic control in an undiagnosed diabetes mellitus patient with Coronavirus Disease 2019
Okonta, N. E., Oloyede, T., Ibrahim, O. R., Yusuf, B. O., Sanda, A., & Suleiman, B. (2020) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_141_20
Obesity as a Poor Prognostic Factor in Multiple Myeloma
Mikhailov, E. S., Salogub, G., & Бессмельцев, С. С. (2021) · Clinical oncohematology · doi:10.21320/2500-2139-2021-14-3-315-320
Eftimov, M., Georgieva, A., & Valcheva-Kuzmanova, S. (2021) · Varna Medical Forum · doi:10.14748/vmf.v0i0.8004
Diana, E. D. N., Nugraha, W., Rahma, A., Frieda, F., Oktafiani, A., Widyaswari, R., & Irawanto, M. E. (2021) · MEDICINUS · doi:10.56951/medicinus.v34i3.79
Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders
Grover, K. M., & Sripathi, N. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758779
Corticoterapia en la práctica reumatológica
Nocturne, G. (2023) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(23)47692-1
Inpatient Management of Diabetes and Hyperglycemia
Horton, W. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_46
Găină, M.-A., Botezatu, I.-E., Petruţ, F.-A., Ştefănescu, B., Găină, A.-M., Galinescu, I., & Ștefănescu, C. (2023) · Psihiatru ro · doi:10.26416/psih.73.2.2023.8258
Khan, S. A., Bhat, S. Z., & Zilbermint, M. F. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_13
Terapia corticosteroidea nella pratica reumatologica
Nocturne, G. (2024) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(24)48829-3
Principles of Care in the Diabetic Surgical Patient
Khazai, N. B., & Hamdy, O. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_6 · Cited by 1
Aydın, E. G. G., Durceylan, E., Angın, Y. S., Basyazici, G., Özkara, E., Çeliksöz, A. H., Yılmaz, E., Ata, A. R., Akarsu, M., ÇINAROĞLU, A., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3173
Huerta, E. J. D., Bojórquez, G. D., Hernández-Guzmán, C. G., Hernández, Ó. N. C., Moreno, C. Z., Díaz, V. E. V., Zavala, E. P., Pérez, B. S., Salinas, A. Á., & Medina, L. F. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16629
Ferrière, A., & Tabarin, A. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.07.002
Fleifel, M., Zoghbi, A. A., Tabaja, J., Alam, A. E., Farraj, K. A., Zaatari, R. A., Skaff, Y., Tabbikha, R., Eid, K., Attieh, R., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5375654
Mit Metformin Glukokortikoid-Nebenwirkungen reduzieren?
Müssig, K. (2025) · Info Diabetologie · doi:10.1007/s15034-025-5142-z
Gityamwi, N., van Even, S., Younes, Y. R., Armes, J., & Field, B. C. T. (2025) · Diabetic Medicine · doi:10.1111/dme.70138
Fleifel, M., Zoghbi, A. A., Tabaja, J., Alam, A. E., Farraj, K. A., Zaatari, R. A., Skaff, Y., Tabbikha, R., Eid, K., Attieh, R., et al. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100280
Cheung, N. W., Hor, A., Marschner, S. L., Chan, C., Min, H., Lee, L., Hng, T., Rhou, Y. J. J., Wu, Y., Wang, M., et al. (2026) · Diabetology · doi:10.3390/diabetology7050094
Drug-induced hyperglycemia in obstetrics: key offending drugs, mechanisms, and practical management
Xu, J., Nguyen, T. N., Liu, T., Jiang, F., Zhao, X., Qin, S., & Yin, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1866528
Misiura, K. V., Seliukova, N. Y., Khoroshun, E. M., Nehoduiko, V. V., Макаров, Д., & Medvedovska, N. V. (2026) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2026.3.03
Metadata
- Authors
- Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Donihi, Amy Calabrese
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 12
- Issue
- 4
- Pages
- 358-362
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W1977503469
- Cited by
- 246
- References
- 13
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 18 · 2021: 15 · 2020: 15 · 2019: 13 · 2018: 21 · 2017: 14 · 2016: 12 · 2015: 15 · 2014: 15 · 2013: 22 · 2012: 13
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Novo Nordisk
- Medical Center, University of Pittsburgh
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- corticosteroid-induced hyperglycemia, hospitalized patients, prednisone, risk factors, prevalence, history of diabetes, length of hospital stay, comorbidities, medical inpatients
- MeSH terms
- Adrenal Cortex Hormones, Adult, Aged, Female, Hospitalization, Humans, Hyperglycemia, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity, Prevalence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review